A microdose clinical trial to evaluate [18F]Florastamin as a positron emission tomography imaging agent in patients with prostate cancer.

Inki LeeIlhan LimByung Hyun ByunByung Il KimChang Woon ChoiSang-Keun WooKyo Chul LeeJoo Hyun KangHee Seup KilChansoo ParkDae Yoon ChiJongwook ParkKanghyon SongSang Moo Lim

Published in: European journal of nuclear medicine and molecular imaging (2020)

KCT0003924 registered at https://cris.nih.go.kr/ .

Keyphrases

positron emission tomography
prostate cancer
clinical trial
computed tomography
radical prostatectomy
high resolution
pet ct
pet imaging
phase ii
double blind
open label
randomized controlled trial
phase iii